Abstract
Rationale Triage is crucial for patient’s management and estimation of the required Intensive Care Unit (ICU) beds is fundamental for Health Systems during the COVID-19 pandemic.
Objective To assess whether chest Computed Tomography (CT) of COVID-19 pneumonia has an incremental role in predicting patient’s admission to ICU.
Methods We performed volumetric and texture analysis of the areas of the affected lung in CT of 115 outpatients with COVID-19 infection presenting to the Emergency Room with dyspnea and unresponsive hypoxyemia. Admission blood laboratory including lymphocyte count, serum lactate dehydrogenase, D-dimer and C-Reactive Protein and the ratio between the arterial partial pressure of oxygen and inspired oxygen were collected. By calculating the areas under the receiver-operating characteristic curves (AUC), we compared the performance of blood laboratory-arterial gas analyses features alone and combined with the CT features in two hybrid models (Hybrid radiological and Hybrid radiomics)for predicting ICU admission. Following a machine learning approach, 63 patients were allocated to the training and 52 to the validation set.
Measurements and Main Results Twenty-nine (25%) of patients were admitted to ICU. The Hybrid radiological model comprising the lung %consolidation performed significantly (p=0.04) better in predicting ICU admission in the validation (AUC=0.82; 95%Confidence Interval 0.68-0.95) set than the blood laboratory-arterial gas analyses features alone (AUC=0.71; 95%Confidence Interval 0.56-0.86). A risk calculator for ICU admission was derived and is available at:https://github.com/cgplab/covidapp
Conclusions The volume of the consolidated lung in CT of patients with COVID-19 pneumonia has a mild but significant incremental value in predicting ICU admission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
none
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study received ethical approval (Protocol Number: 17260_oss) on May 19, 2020 by The Ethical Committee for Clinical Studies of the Central Tuscany Region, Nuovo Ingresso Careggi (NIC) - Largo Brambilla, 3 - 50134 Florence, Italy.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: None
Conflicts of interest/Competing interests: None
Ethics approval: Yes. Ref. number 17260
Consent to participate (include appropriate statements): not applicable
Consent for publication (include appropriate statements): not applicable
Availability of data and material (data transparency): Yes. Requests can be forwarded to Maurizio Bartolucci maurizio.bartolucci{at}uslcentro.toscana.it or Matteo Benelli matteo.benelli{at}uslcentro.toscana.it
Code availability (software application or custom code): yes. Requests can be forwarded to Matteo Benelli matteo.benelli{at}uslcentro.toscana.it
Authors’ contributions: All the authors read and discussed the content of the article. M Ba conceived and performed the study. M Ben performed all statistical analyses, developed and tested the predictive models and realized the web free APP. M Bet, SB, LF and LNM collected and preliminarily elaborated the data. FG performed literature review. DA, MT, GC, ME di N, PL had in charge COVID-19 patients in the Prato and Pistoia Hospitals, LV, SS and RC developed and shared the CT examinations protocol, acquisitions and elaboration strategies. LB supervised the elaboration and analyses pipeline. DM was the Guarantor of the study. M M contributed to the study design, wrote the manuscript draft and critically discussed it. All the authors critically revised the final draft and approved.
Data Availability
Requests can be forwarded to Maurizio Bartolucci maurizio.bartolucci{at}uslcentro.toscana.it or Matteo Benelli matteo.benelli{at}uslcentro.toscana.it
